Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_assertion type Assertion NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_head.
- NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_assertion description "[In this pilot study, we utilized a retroviral vector expressing methylguanine DNA methyltransferase (MGMT) to transduce hematopoietic progenitors, which were subsequently used in the setting of alkylator therapy (procarbazine, CCNU, vincristine (PCV)) for poor prognosis brain tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_provenance.
- NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_assertion evidence source_evidence_literature NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_provenance.
- NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_assertion SIO_000772 16645619 NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_provenance.
- NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_assertion wasDerivedFrom befree-20140225 NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_provenance.
- NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_assertion wasGeneratedBy ECO_0000203 NP297627.RA0mZIideyM3qB6cPRvnr4mtt82qN6pwdq12QGyYhPSrY130_provenance.